Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Accured Expenses (2016 - 2026)

Collegium Pharmaceutical has reported Change in Accured Expenses over the past 10 years, most recently at $10.7 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 52.26% year-over-year to $10.7 million; the TTM value through Dec 2025 reached -$9.5 million, up 75.98%, while the annual FY2025 figure was -$9.5 million, 75.98% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $10.7 million at Collegium Pharmaceutical, up from -$8.1 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $22.4 million in Q4 2024 and troughed at -$62.9 million in Q3 2024.
  • A 5-year average of -$2.7 million and a median of -$249500.0 in 2022 define the central range for Change in Accured Expenses.
  • On a YoY basis, Change in Accured Expenses climbed as much as 1635.09% in 2025 and fell as far as 2777.73% in 2025.
  • Year by year, Change in Accured Expenses stood at $10.8 million in 2021, then increased by 25.76% to $13.6 million in 2022, then tumbled by 62.42% to $5.1 million in 2023, then soared by 339.04% to $22.4 million in 2024, then crashed by 52.26% to $10.7 million in 2025.
  • Business Quant data shows Change in Accured Expenses for COLL at $10.7 million in Q4 2025, -$8.1 million in Q3 2025, and $5.6 million in Q2 2025.